1. Home
  2. TCBK vs NTLA Comparison

TCBK vs NTLA Comparison

Compare TCBK & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriCo Bancshares

TCBK

TriCo Bancshares

HOLD

Current Price

$52.78

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Intellia Therapeutics Inc.

NTLA

Intellia Therapeutics Inc.

SELL

Current Price

$13.00

Market Cap

1.6B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
TCBK
NTLA
Founded
1975
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
TCBK
NTLA
Price
$52.78
$13.00
Analyst Decision
Hold
Buy
Analyst Count
6
20
Target Price
★ $57.84
$23.11
AVG Volume (30 Days)
223.8K
★ 5.2M
Earning Date
10-22-2026
11-09-2026
Dividend Yield
★ 2.73%
N/A
EPS Growth
6.94
★ 27.43
EPS
★ 2.10
N/A
Revenue
$53,445,000.00
★ $67,671,000.00
Revenue This Year
$7.81
N/A
Revenue Next Year
$4.06
$143.36
P/E Ratio
$25.10
★ N/A
Revenue Growth
4.12
★ 16.92
52 Week Low
$43.22
$7.95
52 Week High
$61.71
$18.48

Technical Indicators

Market Signals
Indicator
TCBK
NTLA
Relative Strength Index (RSI) 51.91 61.34
Support Level $52.34 $11.49
Resistance Level $53.05 $13.50
Average True Range (ATR) 0.98 0.76
MACD 0.21 0.09
Stochastic Oscillator 60.38 94.05

Price Performance

Historical Comparison
TCBK
NTLA

About TCBK TriCo Bancshares

TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services, including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of treasury management services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income. Its banking and financial services are provided through full-service branches and commercial banking offices across California.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: